Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

NCT00000875 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

16

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate
DRUG: Diphenhydramine hydrochloride
DRUG: Lymphocytes, Activated
DRUG: Lamivudine
DRUG: Zidovudine
DRUG: Acetaminophen
DRUG: Aldesleukin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)